Wcri

Voyager Therapeutics Inc., based in Cambridge, MA, is a biotechnology company focused on leveraging human genetics to develop transformative medicines for neurological diseases. Their robust pipeline includes genetic therapies targeting conditions such as Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease, utilizing the innovative TRACER AAV capsid discovery platform for optimal delivery across the blood-brain barrier. Dedicated to advancing neurogenetic medicines, Voyager Therapeutics prides itself on its talented workforce and collaborative environment. The company aims to modify the course of debilitating neurological disorders and ultimately find cures through its pioneering research and development efforts. Generated from the website

Schlumberger-Doll Research, located in Cambridge, MA, specializes in brand transformation through an approach known as the "Blink Factor." The company serves a diverse range of markets including financial services, foodservice, consumer packaged goods, health and wellness, corporate retail, and more. With a focus on innovative solutions, Schlumberger-Doll Research employs its expertise to deliver insights and strategies that enhance brand visibility and impact. The firm offers a variety of services, case studies, and resources aimed at engaging clients and addressing unique market challenges. Generated from the website